Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

Early access for patients with unmet medical needs

Many patients around the world struggle to gain access to new therapeutic options. There may be no clinical trials in close proximity or the eligibility requirements are too limiting. In...

- PMLiVE

China weighs heavy on GSK figures in Q3

Pharma company loses two thirds of sales in region after scandal-hit period

- PMLiVE

Celgene’s Revlimid knocked-back by NICE

Final draft guidance from NICE does not recommend drug for rare bone marrow disorder

- PMLiVE

Priority review for Lilly’s ramucirumab in gastric cancer

Update comes as company posts improved revenue results

- PMLiVE

Senior banker joins Lilly’s board

Jackson Tai is former CEO of the Asian financial firm DBS

- PMLiVE

Publicis Groupe adds to Indian portfolio

Comms group acquires Beehive Communications

- PMLiVE

UK PR body bids to stop theft of pitch ideas

Public Relations Consultants Association plans to help agencies safeguard their intellectual property

- PMLiVE

It’s time for growth

Time for pharma marketers to get back to what they do best

- PMLiVE

New head at Cardiovascular Research Foundation

Jack Lewin is former CEO of American College of Cardiology and the California Medical Association

- PMLiVE

Roche signs biologics partnership with Samsung

Manufacturing deal follows investment in pharma firm's own capabilities

- PMLiVE

Amgen buys total filgrastim rights from Roche

Wrests control of white blood cell stimulator franchise

Novartis building

NICE backs Novartis/ ThromboGenics’ eye drug

Recommends Jetrea for NHS use in England and Wales to treat the rare disease vitreomacular traction

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links